Literature DB >> 19782552

Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study.

Ma Cecilia García-Sancho Figueroa1, Guillermo Carrillo, Rogelio Pérez-Padilla, Ma Rosario Fernández-Plata, Ivette Buendía-Roldán, Mario H Vargas, Moisés Selman.   

Abstract

The etiology of idiopathic pulmonary fibrosis (IPF) remains poorly understood, but some studies have suggested that cigarette smoking or other occupational or environmental exposures, diabetes mellitus, or gastroesophageal reflux may play a role. In this study we evaluated the clinical records of a group of 97 consecutive patients with IPF, and 560 patients suffering 5 different respiratory disorders that were examined as controls: asthma (n=111), chronic obstructive pulmonary disease (n=132), squamous cell lung carcinoma (n=118), lung adenocarcinoma (n=101) and patients with otorhinolaryngology problems but without lung disease (n=98). In bivariate analyses male sex, diabetes mellitus and being former cigarette smoker were associated with IPF. After adjusting by these variables, multivariate analysis revealed that type 2 diabetes mellitus [11.3% in IPF patients vs 2.9% in controls, OR=4.3 (95% CI: 1.9-9.8), p<0.0001] was an independent risk factor associated to IPF. Our results provide additional evidence of a putative relationship between DM2 and idiopathic pulmonary fibrosis. Experimental research is necessary for thorough assessment of the pathogenic mechanisms involved in this association.

Entities:  

Mesh:

Year:  2009        PMID: 19782552     DOI: 10.1016/j.rmed.2009.08.013

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  30 in total

Review 1.  Telomerase and idiopathic pulmonary fibrosis.

Authors:  Mary Armanios
Journal:  Mutat Res       Date:  2011-11-04       Impact factor: 2.433

Review 2.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 3.  Epigenomics of idiopathic pulmonary fibrosis.

Authors:  Ivana V Yang
Journal:  Epigenomics       Date:  2012-04       Impact factor: 4.778

4.  Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.

Authors:  Martha L Bustos; Luai Huleihel; Maria G Kapetanaki; Christian L Lino-Cardenas; Lyle Mroz; Bryon M Ellis; Bryan J McVerry; Thomas J Richards; Naftali Kaminski; Nayra Cerdenes; Ana L Mora; Mauricio Rojas
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

Review 5.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.

Authors:  Qiang Ding; Tracy Luckhardt; Louise Hecker; Yong Zhou; Gang Liu; Veena B Antony; Joao deAndrade; Victor J Thannickal
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

6.  Workshop on idiopathic pulmonary fibrosis in older adults.

Authors:  Richard J Castriotta; Basil A Eldadah; W Michael Foster; Jeffrey B Halter; William R Hazzard; James P Kiley; Talmadge E King; Frances McFarland Horne; Susan G Nayfield; Herbert Y Reynolds; Kenneth E Schmader; Galen B Toews; Kevin P High
Journal:  Chest       Date:  2010-09       Impact factor: 9.410

Review 7.  Epigenetics of idiopathic pulmonary fibrosis.

Authors:  Ivana V Yang; David A Schwartz
Journal:  Transl Res       Date:  2014-03-31       Impact factor: 7.012

8.  Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses.

Authors:  Yeonkyung Park; Chiwon Ahn; Tae-Hyung Kim
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

9.  Risk factors for the development of idiopathic pulmonary fibrosis: A review.

Authors:  Tanzira Zaman; Joyce S Lee
Journal:  Curr Pulmonol Rep       Date:  2018-10-16

10.  Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.

Authors:  S K Huang; A M Scruggs; J Donaghy; J C Horowitz; Z Zaslona; S Przybranowski; E S White; M Peters-Golden
Journal:  Cell Death Dis       Date:  2013-05-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.